CBIO Income Statement


* In Millions (except for per share items) of USD
Period Ending: LTM
(Last Twelve Months)
2023 (Q3)
09-30
2023 (Q2)
06-30
2023 (Q1)
03-31
2022 (Q4)
12-31
2022 (Q3)
09-30
2022 (Q2)
06-30
2022 (Q1)
03-31
2021 (Q4)
12-31
2021 (Q3)
09-30
2021 (Q2)
06-30
2021 (Q1)
03-31
2020 (Q4)
12-31
2020 (Q3)
09-30
2020 (Q2)
06-30
2020 (Q1)
03-31
2019 (Q4)
12-31
2019 (Q3)
09-30
2019 (Q2)
06-30
2019 (Q1)
03-31
2018 (Q4)
12-31
2018 (Q3)
09-30
2018 (Q2)
06-30
2018 (Q1)
03-31
2017 (Q4)
12-31
2017 (Q3)
09-30
2017 (Q2)
06-30
2017 (Q1)
03-31
2016 (Q4)
12-31
2016 (Q3)
09-30
2016 (Q2)
06-30
2016 (Q1)
03-31
2015 (Q4)
12-31
2015 (Q3)
09-30
2015 (Q2)
06-30
2015 (Q1)
03-31
2014 (Q4)
12-31
2014 (Q3)
09-30
2014 (Q2)
06-30
2014 (Q1)
03-31
2013 (Q4)
12-31
2013 (Q3)
09-30
2013 (Q2)
06-30
2013 (Q1)
03-31
2012 (Q4)
12-31
2012 (Q3)
09-30
2012 (Q2)
06-30
2012 (Q1)
03-31
2011 (Q4)
12-31
2011 (Q3)
09-30
2011 (Q2)
06-30
2011 (Q1)
03-31
2010 (Q4)
12-31
2010 (Q3)
09-30
2010 (Q2)
06-30
2010 (Q1)
03-31
2009 (Q4)
12-31
2009 (Q3)
09-30
2009 (Q2)
06-30
2009 (Q1)
03-31
2008 (Q4)
12-31
2008 (Q3)
09-30
2008 (Q2)
06-30
2008 (Q1)
03-31
2007 (Q4)
12-31
2007 (Q3)
09-30
2007 (Q2)
06-30
2007 (Q1)
03-31
2006 (Q4)
12-31
2006 (Q3)
09-30
2006 (Q2)
06-30
2006 (Q1)
03-31
2005 (Q4)
12-31
2005 (Q3)
09-30
2005 (Q2)
06-30
2005 (Q1)
03-31
Report Filing: 2023-10-26 2023-08-14 2023-05-15 2023-03-30 2022-11-14 2022-08-15
1234
Revenue 0 0 0 -794000 0 0
1234
Cost of Revenue 0 318000 588000 798000 803000 1871000
1234
Gross Profit 0 -318000 -588000 -1592000 -803000 -1871000
1234
Operating Expenses 1623000 2225000 -766000 38682000 4363000 -53401000
1234
Research & Development 415000 318000 588000 660000 803000 1871000
1234
Selling, General and Administrative 2408000 2225000 3970000 4165000 4363000 3844000
1234
Other Operating Expenses -1200000 -318000 -5324000 33857000 -803000 -59116000
1234
Operating Income -1623000 -2543000 178000 -40274000 -5166000 51530000
1234
Net Interest(Non Operating) 47000 73000 192000 -549000 282000 0
1234
Interest Income 47000 73000 96000 167000 283000 102000
1234
Interest Expense 0 0 -96000 716000 1000 102000
1234
Equity & Other Income/(Expense) 0 0 -96000 717000 0 102000
1234
Income Before Tax -1576000 -2470000 274000 -40106000 -4884000 51632000
1234
Income Tax Expense 0 2000 14000 348000 -282000 -57347000
1234
Income Attributable to Non-Controlling Interest 0 0 0 0 0 57347000
1234
Net Income -1576000 -2472000 260000 -40454000 -4602000 51632000
1234
Depreciation and Amortization 0 1000 -9469000 12933000 323000 67000
1234
EBITDA -1623000 -2542000 -9291000 -27341000 -4843000 51597000
1234
Earnings Per Share (EPS) -0.0415 -0.0654 0.01 -1.28 -0.15 1.64
1234
Diluted Earnings Per Share -0.0415 -0.0654 0.01 -1.28 -0.15 1.64
1234
Weighted Average Shares Outstanding 37976764 37800121 37758416 31545723 30525000 31477053
1234
Diluted Weighted Average Shares Outstanding 37976764 37800121 37984324 31545723 31484542 31482925
1234

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.